Shifts in US pricing reforms are set to grant US healthcare systems the patient access and affordability it’s been yearning for. While regulatory changes are in motion to positively impact the healthcare system, Market Access leaders will need to truly put patient centricity at the forefront of all submission strategies to succeed in shifting price control, payer negotiations, formularies, and pharma’s future innovation.

It’s never been a more important time to innovate value-based agreements, enhance real world data, and engage critical stakeholders in product cycle preparations ahead of new launches and negotiations with payers – both in the short and long term.

This webinar will host a panel of Market Access experts who will contribute their insights to:

 
• Develop frictionless and affordable paths to access through an updated framework of IRA changes, and their                cascading impact on pricing, payers, formularies and patients
• Succeed in payer negotiations through patient involvement during early-stage pipeline and planning
• Leverage patient-focused real world data to inform future outcomes and strengthen payer value